Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.218 EUR | -3.39% |
|
+10.25% | +92.75% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock
- News Hansa Biopharma AB
- Other languages